openPR Logo
Press release

Chronic Kidney Disease Drugs Market to reach USD 18.21 Bn by 2029, emerging at a CAGR of 5.6 percent and forecast 2023-2029

Chronic Kidney Disease Drugs Market

Chronic Kidney Disease Drugs Market

Chronic Kidney Disease Drugs Market Report Scope and Research Methodology

The Chronic Kidney Disease Drugs Market, valued at USD 12.43 Bn. in 2022, is anticipated to witness a robust growth rate of 5.6% from 2023 to 2029, reaching a projected value of USD 18.21 Bn.

Maximize Market Research Pvt Ltd releases an in-depth market research report on the Chronic Kidney Disease Drugs Market. The report provides comprehensive insights into the market size, drivers, restraints, and regional dynamics. Chronic kidney disease, a significant public health concern affecting 15% of adults in the United States and over 850 million people globally, demands a thorough examination of its pharmaceutical landscape.

Our report is backed by a rigorous research methodology, ensuring accuracy and reliability. Through a combination of primary and secondary research, our analysts have gathered valuable data, enabling a detailed understanding of market trends and dynamics.

Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/market-report/global-chronic-kidney-disease-ckd-drugs-market/39171/

Chronic Kidney Disease Drugs Market Dynamics:

The rising prevalence of diseases such as diabetes, hypertension, and other renal disorders is a key driver for the growing demand in the global kidney disease medications market. Additionally, the increasing need for effective pharmaceuticals for chronic disease diagnostics further fuels market growth.

Medication dosing errors and medication-related complications pose significant challenges in treating patients with chronic kidney disease. The complexity of prescription regimens increases the risk of complications, emphasizing the need for careful management and collaboration between healthcare professionals.

Chronic Kidney Disease Drugs Market Regional Insights:

North America: Dominated the market in 2022 with a focus on improving healthcare infrastructure and attractive reimbursement policies.

Asia Pacific: Accounted for the highest revenue share (24.00%) due to increased healthcare spending, government initiatives, and awareness campaigns.

Middle East and Africa: Expected to follow Asia Pacific in terms of growth, with a higher prevalence of CKD in the region.

Request For Free Inquiry Report:https://www.maximizemarketresearch.com/inquiry-before-buying/39171

Chronic Kidney Disease Drugs Market Segmentation:

by Drug Class

ACE Inhibitors
Angiotensin-II Receptor Blockers
Calcium Channel Blockers
Beta Blockers
Erythropoiesis-Stimulating Agents (Esas)
Diuretics
Others

by End User

Hospitals
Specialty Clinics

Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/market-report/global-chronic-kidney-disease-ckd-drugs-market/39171/

Chronic Kidney Disease Drugs Market Key Players:

1. Keryx Biopharmaceuticals, Inc. (US)
2. DiaMedica Therapeutics Inc.(US)
3. AbbVie, Inc.(US)
4. Allergan plc.(US)
5. Amgen Inc.(US)
6. Kidney Fibrosis(US)
7. Allena Pharmaceuticals Inc.(US)
8. NovaTarg Therapeutics Inc.(US)
9. KBP BioSciences Co Ltd.(US)
10.IC-MedTech Inc.(US)
11.OPKO Health Inc.(US)
12.Q BioMed Inc(US)
13.Unity Biotechnology Inc.(US)
14.KBP BioSciences Co Ltd(US)
15.FibroGen(US)
16.Johnson & Johnson(US)
17.Akebia Therapeutics, Inc.(US)
18.Pfizer, Inc.(US)
19.Kissei Pharmaceutical Co., Ltd. (Japan)
20.Astellas Pharma Inc.(Japan)
21.Taisho Pharmaceutical Holdings Co Ltd.(Japan)
22.GlaxoSmithKline plc.(UK)
23.AstraZeneca plc(UK)
24.Sanofi S.A.(France)
25.Les Laboratoires Servier SAS(France)

Get to Know More About This Market Study:https://www.maximizemarketresearch.com/market-report/global-chronic-kidney-disease-ckd-drugs-market/39171/

1.Global Chronic Kidney Disease Drugs Market: Research Methodology

2.Global Chronic Kidney Disease Drugs Market: Executive Summary

Market Overview and Definitions
Introduction to the Global Market
Summary
Key Findings
Recommendations for Investors
Recommendations for Market Leaders
Recommendations for New Market Entry

3.Global Chronic Kidney Disease Drugs Market: Competitive Analysis

MMR Competition Matrix
Market Structure by region
Competitive Benchmarking of Key Players
Consolidation in the Market
M&A by region
Key Developments by Companies
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Market Dynamics
PORTERS Five Forces Analysis
PESTLE
Regulatory Landscape by region
North America
Europe
Asia Pacific
Middle East and Africa
South America
COVID-19 Impact

4 . Company Profile: Key players

Company Overview
Financial Overview
Global Presence
Capacity Portfolio
Business Strategy
Recent Developments

Key Offerings:

Past Market Size and Competitive Landscape (2022 to 2029)
Past Pricing and price curve by region (2022 to 2029)
Market Size, Share, Size and Forecast by different segment | 2022-2029
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Market Segmentation - A detailed analysis by growth and trend
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations

Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 mailto:sales@maximizemarketresearch.com
🌐 https://www.maximizemarketresearch.com

About Maximize Market Research:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Kidney Disease Drugs Market to reach USD 18.21 Bn by 2029, emerging at a CAGR of 5.6 percent and forecast 2023-2029 here

News-ID: 3286816 • Views:

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
The Courier Services Market size was valued at USD 453.56 Billion in 2024 and the total Courier Services revenue is expected to grow at a CAGR of 5.8% from 2025 to 2032, reaching nearly USD 712.07 Billion. Courier Services Market Overview The global Courier Services Market has experienced significant growth, driven by the rising adoption of e-commerce, growing Internet penetration, and changing consumer lifestyles. Courier services provide quick, door-to-door delivery solutions for
WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market was valued at USD 6.47 Billion in 2023, and it is expected to reach USD 17.83 Billion by 2030, exhibiting a CAGR of 15.58% during the forecast period (2024-2030). WealthTech Solutions Market Overview The global WealthTech Solutions Market is undergoing a transformative phase, driven by changing customer preferences, digital innovation, and evolving financial landscapes. WealthTech solutions provide digital tools and platforms that enhance operational efficiency for financial advisors, wealth
Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR Growth
Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR G …
Global Rapid Test Market size was valued at USD 40.75 Bn. in 2024 and the total Rapid Test Market is expected to grow by 8.81% from 2025 to 2032, reaching nearly USD 80.07 Bn. Rapid Test Market Overview The global Rapid Test Market is witnessing significant growth, driven by the increasing demand for fast, accessible diagnostic solutions across healthcare settings and home-care applications. Rapid tests are designed to detect the presence of
Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAGR Growth
Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAG …
Global Agarwood Oil Market size is expected to reach nearly US$ 496.84 Mn by 2032 with the CAGR of 5.42% during the forecast period. Agarwood Oil Market Overview Agarwood Oil, derived from the resinous wood of Aquilaria trees primarily found in Southeast Asia, is highly valued for its aromatic and therapeutic properties. Formed when the wood is infected by yeast, pests, or microbes, the oil possesses antimicrobial, antioxidant, anti-inflammatory making it widely

All 5 Releases


More Releases for Chronic

Chronic Pain Treatment Market - Relieving Chronic Pain: Discover the Latest Inno …
Newark, New Castle, USA: The "Chronic Pain Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Chronic Pain Treatment Market: https://www.growthplusreports.com/report/chronic-pain-treatment-market/8030 This latest report researches the industry structure,
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991 This latest report researches the
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Chronic Hepatitis Therapeutics Market - Empowering Liver Health, Defying Chronic …
Newark, New Castle, USA - new report, titled Chronic Hepatitis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Hepatitis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Hepatitis Therapeutics market. The report offers an overview of
Chronic Phase Chronic Myeloid Leukemia Market to Witness Growth by 2032, Estimat …
DelveInsight's "Chronic Phase Chronic Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Phase Chronic Myeloid Leukemia , historical and forecasted epidemiology as well as the Chronic Phase Chronic Myeloid Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Phase Chronic Myeloid Leukemia market report provides current treatment practices, emerging drugs, the market share
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them